abnormal control plasma biophen (QUADRATECH DIAGNOSTICS LIMITED)
90
Structured Review
QUADRATECH DIAGNOSTICS LIMITED
abnormal control plasma biophen
Abnormal Control Plasma Biophen, supplied by QUADRATECH DIAGNOSTICS LIMITED, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/abnormal+control+plasma+biophen/abnormal+control+plasma+biophen/pm21041718-73-0-4
Average 90 stars, based on 1 article reviews
Abnormal Control Plasma Biophen, supplied by QUADRATECH DIAGNOSTICS LIMITED, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/abnormal+control+plasma+biophen/abnormal+control+plasma+biophen/pm21041718-73-0-4
Average 90 stars, based on 1 article reviews
abnormal control plasma biophen - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Control:Article Title: Codon optimization of human factor VIII cDNAs leads to high-level expression. Article Snippet: 1Molecular Immunology Unit, Institute of Child Health, University College London, London, United Kingdom; 2Department of Haematology, Haemophilia Centre and Haemostasis Unit, University College Medical School, London, United Kingdom; 3Institute for Women’s Health, University College London, London, United Kingdom; 4Flanders Institute for Biotechnology (VIB), Vesalius Research Center, University of Leuven, Leuven, Belgium; 5Free University of Brussels, Faculty of Medicine & Pharmacy, Brussels, Belgium; 6Department of Haematology, University College London, United Kingdom; and 7Molecular Medicine, Thrombosis Research Institute, London, United Kingdom Clinical Proteomics:Article Title: Codon optimization of human factor VIII cDNAs leads to high-level expression. Article Snippet: 1Molecular Immunology Unit, Institute of Child Health, University College London, London, United Kingdom; 2Department of Haematology, Haemophilia Centre and Haemostasis Unit, University College Medical School, London, United Kingdom; 3Institute for Women’s Health, University College London, London, United Kingdom; 4Flanders Institute for Biotechnology (VIB), Vesalius Research Center, University of Leuven, Leuven, Belgium; 5Free University of Brussels, Faculty of Medicine & Pharmacy, Brussels, Belgium; 6Department of Haematology, University College London, United Kingdom; and 7Molecular Medicine, Thrombosis Research Institute, London, United Kingdom |